PlainRecalls
FDA Drug Moderate Class II Terminated

MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05

Reported: February 8, 2017 Initiated: December 16, 2016 #D-0456-2017

Product Description

MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
47, 020 vials
Distribution
Nationwide and Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
MIDAZOLAM INJECTION, USP, *25 mg/5 mL, (5 mg/ mL), 5 mL vials, 10 Vials per carton, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173 --- NDC 63323-412-05. Recalled by Fresenius Kabi USA, LLC. Units affected: 47, 020 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on February 8, 2017. Severity: Moderate. Recall number: D-0456-2017.